Find a Tender Service

Gene testing and reporting for Ovarian cancer specimens

NHS Greater Glasgow and Clyde

Awarded
services
Scotland

This services contract from NHS Greater Glasgow and Clyde is closed to new bids. It was awarded to Myriad Genetics for £363,000 on 12 Nov 2026. Region: Scotland. Procedure: Award procedure without prior publication of a call for competition.

Live now: tenders like this

Get tenders like this by email

New tenders like this one, in your inbox every morning. Starts with 14 days of Pro, no card needed.

Unsubscribe in one click. See our privacy policy.

Key details

Contracting authority
Region
Scotland
Location: Glasgow
Delivery: Glasgow City
Contract value
£363,000ex VAT
Published
19 November 2026

Procurement

Procedure type
Award procedure without prior publication of a call for competition
CPV classifications

Description

NHS Greater Glasgow and Clyde, Laboratory Genetics requires an end-to-end diagnostic service for FFPE block processing, DNA based Homologous Repair Deficiency (HRD) and BRCA1 and BRCA2 gene testing and reporting for Ovarian cancer specimens. This service is required for approximately 200 tests per annum and the service must be available by 1st December 2026.

Full description

NHS Greater Glasgow and Clyde requires an end-to-end diagnostic service for FFPE block processing, DNA based Homologous Repair Deficiency (HRD) and BRCA1 and BRCA2 gene testing and reporting for Ovarian cancer specimens. The technical processing and laboratory reporting must be validated to ISO 15189 (2022) standards or equivalent and the underlying technology used must be clinically validated with demonstrable assessment against clinical outcomes.

The service must have a robust trackability process to ensure that FFPE blocks are processed sensitively and returned to Laboratory Genetics NHS GGC.

This service is required for approximately 200 tests per annum and the service must be available by 1st December 2026.

The provider must be able to meet NHS GGC boards Information Technology and Security and Information Governance frameworks by completion of Data Protection Impact Assessment (DPIA), and establishing a Data Processing Agreement (DPA) along with a Systems Security Policy (SSP) as applicable. All information governance, cyber-security and any contractual agreements must be established and in place by 01/12/2026 as the current HRD service, based within the UK, will cease to exist from 01/12/2026.

The supplier must be able to provide a fixed cost per test, between 01/12/2026-31/12/2027.

There are no Scottish Genomic Laboratories able to provide this test. We require a rapid solution to ensure that patients needing the HRD test can access the test and associated treatment pathways based on the test result. Not having a test available for this patient cohort will lead to significant patient harm and even early death. Additional information: Contract valid 01/12/2026 - 31/12/2027

Awarded supplier

Award value
£363,000
Award date
12 November 2026

Contact

Address
Procurement Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF

Identifiers

Notice ID
109560-2026
OCID
ocds-h6vhtk-07bf2e

Explore related tenders

External ID: fts-ocds-h6vhtk-07bf2e • Added 19 November 2026

Get tenders like these by email

Tell us what you do and where you work. Every morning you get the new tenders that fit, from national portals and the buyer portals most services miss.

14 days of Pro, no card. Then Free unless you upgrade.